Cellosaurus RPMI-8226/Dox40 (CVCL_J431)

Cell line name RPMI-8226/Dox40
Synonyms RPMI 8226/DOX40; RPMI-8226DOX40; 8226/DOX40; 8226/Dox40; 8226/Dox(40); 8226 Dox40; Dox40
Accession CVCL_J431
Resource Identification Initiative To cite this cell line use: RPMI-8226/Dox40 (RRID:CVCL_J431)
Comments Characteristics: Produces IgG lambda.
Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
Sequence variation: Heterozygous for EGFR p.Thr751Ile (from parent cell line).
Sequence variation: Heterozygous for KRAS p.Gly12Ala (from parent cell line).
Sequence variation: Homozygous for TP53 p.Glu285Lys (from parent cell line).
Derived from sampling site: Peripheral blood.
Disease Plasma cell myeloma (NCIt: C3242)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_0014 (RPMI-8226)
Children: CVCL_J433 (RPMI-8226/MDR10V)
Sex of cell Male
Category Cancer cell line
Publications

PubMed=2569359
Tong A.W., Lee J., Wang R.-M., Dalton W.S., Tsuruo T., Fay J.W., Stone M.J.
Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibody.
Cancer Res. 49:4829-4834(1989)

PubMed=10095106; DOI=10.1016/S0378-1119(99)00042-6
Duan Z., Feller A.J., Toh H.C., Makastorsis T., Seiden M.V.
TRAG-3, a novel gene, isolated from a taxol-resistant ovarian carcinoma cell line.
Gene 229:75-81(1999)

PubMed=10825126
Scheffer G.L., Maliepaard M., Pijnenborg A.C.L.M., van Gastelen M.A., de Jong M.C., Schroeijers A.B., van der Kolk D.M., Allen J.D., Ross D.D., van der Valk P., Dalton W.S., Schellens J.H.M., Scheper R.J.
Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines.
Cancer Res. 60:2589-2593(2000)

PubMed=11309308
Maliepaard M., Scheffer G.L., Faneyte I.F., van Gastelen M.A., Pijnenborg A.C.L.M., Schinkel A.H., van De Vijver M.J., Scheper R.J., Schellens J.H.M.
Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.
Cancer Res. 61:3458-3464(2001)